Currently browsing all articles within: News
The medical journal “Pediatric Blood and Cancer”, recently published an article on the cost of childhood cancer. Through the lens of a literature review, the paper examined three categories of costs — direct, indirect, and psychosocial costs.
Today, researchers from SickKids Hospital announced their results from recent laboratory research examining the effect of a drug called Imetelstat on telomerase inhibition.
In 2011, Neuroblastoma Canada will formally launch a mentoring program available to Canadian neuroblastoma families and their extended networks. We are now gathering names of people who would like to volunteer their time to be a mentor to a newly diagnosed family. And, if you are looking for mentoring support, please let us know.